CCAP Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Crescent Capital BDC Inc (CCAP) does not present a compelling buy opportunity at this time for a beginner investor focused on long-term investment. The technical indicators are bearish, options data suggests a negative sentiment, and analysts have reduced price targets. Additionally, there are no recent positive news or catalysts to support a strong upward move in the stock price.
The technical indicators for CCAP are bearish. The MACD histogram is positive but contracting, RSI is neutral at 42.958, and moving averages show a bearish pattern (SMA_200 > SMA_20 > SMA_5). The stock is trading below key pivot levels, with resistance at 11.415 and support at 11.048. The stock trend analysis suggests a 60% chance of further declines (-2% in the next day, -4.8% in the next week, -5.89% in the next month).
Management has reduced the base management fee and incentive fee, which improves the fee structure. The dividend has been adjusted to support forward net interest income coverage.
Analysts have lowered price targets, citing portfolio yield compression and refinancing concerns. The stock has a bearish technical setup, and options data reflects negative sentiment. There are no recent news events or significant trading trends from hedge funds or insiders to act as positive catalysts.
No financial data is available for the latest quarter, making it difficult to assess the company's recent growth trends.
Analysts have mixed views but lean towards caution. Recent ratings include downgrades and reduced price targets. Oppenheimer downgraded the stock to Perform with a price target of $16 (down from $19), while B. Riley upgraded it to Buy with a $13.50 price target. The average price target is below the previous highs, reflecting limited upside potential.
